Emollients with endocannabinoids in the treatment of uremic pruritus: discussion of the therapeutic options.
Szepietowski
Jacek C
JC
Reich
Adam
A
Szepietowski
Tomasz
T
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000577:Amides; D063385:Cannabinoid Receptor Modulators / Q000627:therapeutic use*; D004643:Emollients / Q000627:therapeutic use*; D063388:Endocannabinoids; D019856:Ethanolamine / Q000627:therapeutic use; D004983:Ethanolamines; D005260:Female; D005500:Follow-Up Studies; D005780:Gelatin; D006801:Humans; D008297:Male; D008875:Middle Aged; D010169:Palmitic Acids / Q000627:therapeutic use; D011537:Pruritus / Q000209:etiology / Q000628:therapy*; D006435:Renal Dialysis; D017592:Skin Care; D014511:Uremia / Q000150:complications*
D000577:Amides; D063385:Cannabinoid Receptor Modulators; D004643:Emollients; D063388:Endocannabinoids; D004983:Ethanolamines; D010169:Palmitic Acids; D019856:Ethanolamine; C005958:palmidrol; D005780:Gelatin; C042021:physiogel